Sign in

CIK 0001661059

  • Non-accelerated filer
  • Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475231247
Phone
+1 240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
Open-market buys, last 90 days
$140,487
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$140,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$140K 10% owner 3 filings
Date Insider Transaction Shares Price Value Owned after
2019-05-13 Sofinnova Venture Partners IX, L.P. 10% owner Purchase +400,000 $15.00 $6.0M 2,521,856
2019-05-13 SHANNON TIMOTHY M Director Purchase +50,000 $15.00 $750K 2,254,442
2019-05-13 Khuong Chau Quang Director Purchase +350,000 $15.00 $5.3M 2,711,013
2019-05-13 Xu Stella Director Purchase +125,000 $15.00 $1.9M 1,103,570
2019-05-13 CANAAN X L.P. 10% owner Purchase +50,000 $15.00 $750K 2,254,442
2019-05-13 ORBIMED ADVISORS LLC Director Purchase +350,000 $15.00 $5.3M 2,711,013

Page 2 of 2 · 26 trades